Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
130,429,523
-
Share change
-
-20,139,316
-
Total reported value
-
$290,846,970
-
Put/Call ratio
-
204%
-
Price per share
-
$2.23
-
Number of holders
-
144
-
Value change
-
-$60,644,835
-
Number of buys
-
74
-
Number of sells
-
62
Institutional Holders of SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) as of Q4 2017
As of 31 Dec 2017,
SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) was held by
144 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
130,429,523 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, Vanguard Group Inc, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Nantahala Capital Management, LLC, PAULSON & CO. INC., PICTET ASSET MANAGEMENT LTD, NORTHERN TRUST CORP, JPMORGAN CHASE & CO, and UBS Group AG.
This page lists
144
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.